Actionable insights straight to your inbox

Equities logo

Quant Quake 2.0 and QE Infinity Unnerving Investors?

As momentum stocks suffer a sharp sell-off, value names are back in play.
It’s been a big year for biotech. Heck, it’s been a big year for most of the health care sector, but biotech’s been among the biggest gainers across the entire market, with the
Biotech stocks continued a rough week on Wednesday, with the iShares Nasdaq Biotechnology Fund ($IBB) down more than 2.5 percent in early trading, and off by almost 9 percent since Monday. This